Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Julphar
Colorcon
Cipla
Farmers Insurance
Mallinckrodt
McKesson
Cerilliant
Johnson and Johnson
Covington

Generated: December 12, 2017

DrugPatentWatch Database Preview

OLANZAPINE Drug Profile

« Back to Dashboard

When do Olanzapine patents expire, and when can generic versions of Olanzapine launch?

Olanzapine is a drug marketed by Luitpold, Sandoz Inc, Ajanta Pharma Ltd, Apotex Inc, Aurobindo Pharma Ltd, Barr Labs Inc, Dr Reddys Labs Ltd, Invagen Pharms, Jubilant Generics, Macleods Pharms Ltd, Mylan Pharms Inc, Orchid Hlthcare, Par Pharm, Sun Pharm Inds, Torrent Pharms Llc, Alkem Labs Ltd, Hikma Pharms, Ivax Pharms Inc, Qilu Pharm Co Ltd, Teva Pharms, Torrent Pharms Ltd, and Sandoz. and is included in thirty-five NDAs.

The generic ingredient in OLANZAPINE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Apotex IncOLANZAPINEolanzapineTABLET;ORAL090798-006Apr 23, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Macleods Pharms LtdOLANZAPINEolanzapineTABLET;ORAL202862-004Aug 15, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareOLANZAPINEolanzapineTABLET, ORALLY DISINTEGRATING;ORAL202937-003Mar 2, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Macleods Pharms LtdOLANZAPINEolanzapineTABLET, ORALLY DISINTEGRATING;ORAL203044-002Feb 20, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma PharmsOLANZAPINEolanzapineTABLET;ORAL204866-002Jun 16, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareOLANZAPINEolanzapineTABLET;ORAL202287-005Apr 23, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL077742-003Nov 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm IndsOLANZAPINEolanzapineTABLET, ORALLY DISINTEGRATING;ORAL090881-003Feb 28, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareOLANZAPINEolanzapineTABLET;ORAL202287-002Apr 23, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ajanta Pharma LtdOLANZAPINEolanzapineTABLET;ORAL206711-006Aug 30, 2016DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Boehringer Ingelheim
Daiichi Sankyo
Argus Health
Healthtrust
Colorcon
Chubb
QuintilesIMS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot